HIM
CNST

Hillhouse Investment Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Hillhouse Investment Management’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$3.9M Hold
317,921
– – 0.12% 32
2019
Q1 		$4.31M Hold
317,921
– – 0.18% 30
2018
Q4 		$1.27M Hold
317,921
– – 0.1% 23
2018
Q3 		$2.14M Buy
+317,921
New +$3.03M 0.06% 48

Other funds holding CNST

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hillhouse Investment Management's CNST Position: Q2 2019 in Review

Hillhouse Investment Management held its Constellation Pharmaceuticals, Inc. (CNST) position steady in Q2 2019 at 317,921 shares worth $3.9M. The position accounts for 0.12% of the portfolio, ranked #32.

Hillhouse Investment Management first reported a position in CNST in Q3 2018 and has held it in 4 quarters since. The position peaked at $4.31M in Q1 2019. 50 funds tracked by Wall St. Rank hold CNST as of Q2 2019.

  • Hillhouse Investment Management held 317,921 shares of Constellation Pharmaceuticals, Inc. worth $3.9M as of Q2 2019.
  • Hillhouse Investment Management left its Constellation Pharmaceuticals, Inc. share count unchanged in Q2 2019.
  • Constellation Pharmaceuticals, Inc. made up 0.12% of Hillhouse Investment Management's portfolio in Q2 2019, its #32 holding.
  • Hillhouse Investment Management first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2018 and has held it in 4 quarters since.
  • Hillhouse Investment Management's Constellation Pharmaceuticals, Inc. position peaked at $4.31M in Q1 2019.
  • 50 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2019.

Based on Hillhouse Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.